---
title: "12 Health Care Stocks Moving In Friday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299492452.md"
description: "During Friday's after-market session, several healthcare stocks experienced significant volatility. Gainers included DataMEDS AI (+12.9%), Geovax Labs (+9.27%), and Alaunos Therapeutics (+9.16%). Conversely, losers featured IM Cannabis (-11.3%), Citius Oncology (-8.78%), and Telomir Pharmaceuticals (-8.0%). The report highlights specific price movements and market capitalizations for these companies."
datetime: "2026-09-18T21:06:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299492452.md)
  - [en](https://longbridge.com/en/news/299492452.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299492452.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Friday's After-Market Session

### Gainers

-   **DataMEDS AI** (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-market session. The market value of their outstanding shares is at $14.8 million.
-   **Geovax Labs** (NASDAQ:GOVX) stock rose 9.27% to $0.39. The market value of their outstanding shares is at $1.9 million.
-   **Alaunos Therapeutics** (NASDAQ:TCRT) stock moved upwards by 9.16% to $1.31. The market value of their outstanding shares is at $4.0 million.
-   **BGM Group** (NASDAQ:BGM) stock rose 7.56% to $0.27. The market value of their outstanding shares is at $103.7 million.
-   **Apimeds Pharmaceuticals** (AMEX:APUS) shares moved upwards by 6.77% to $1.89. The company's market cap stands at $2.5 million.
-   **Gossamer Bio** (NASDAQ:GOSS) stock increased by 6.33% to $11.41. The company's market cap stands at $73.0 million.

### Losers

-   **IM Cannabis** (NASDAQ:IMCC) stock fell 11.3% to $3.75 during Friday's after-market session. The market value of their outstanding shares is at $1.0 million.
-   **Citius Oncology** (NASDAQ:CTOR) shares declined by 8.78% to $1.04. The market value of their outstanding shares is at $107.8 million.
-   **Telomir Pharmaceuticals** (NASDAQ:TELO) stock declined by 8.0% to $1.13. The market value of their outstanding shares is at $77.0 million.
-   **Pasithea Therapeutics** (NASDAQ:KTTA) stock declined by 7.36% to $0.49. The company's market cap stands at $16.9 million.
-   **Mira Pharmaceuticals** (NASDAQ:MIRA) shares decreased by 6.29% to $0.78. The company's market cap stands at $31.9 million.
-   **Pulsenmore** (NASDAQ:PLSM) stock decreased by 6.25% to $2.25. The company's market cap stands at $15.7 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [GOVXW.US](https://longbridge.com/en/quote/GOVXW.US.md)
- [GOVX.US](https://longbridge.com/en/quote/GOVX.US.md)
- [IMCC.US](https://longbridge.com/en/quote/IMCC.US.md)
- [TCRT.US](https://longbridge.com/en/quote/TCRT.US.md)
- [TELO.US](https://longbridge.com/en/quote/TELO.US.md)
- [MEDS.US](https://longbridge.com/en/quote/MEDS.US.md)
- [BGM.US](https://longbridge.com/en/quote/BGM.US.md)
- [APUS.US](https://longbridge.com/en/quote/APUS.US.md)
- [GOSS.US](https://longbridge.com/en/quote/GOSS.US.md)
- [CTOR.US](https://longbridge.com/en/quote/CTOR.US.md)
- [KTTA.US](https://longbridge.com/en/quote/KTTA.US.md)
- [MIRA.US](https://longbridge.com/en/quote/MIRA.US.md)
- [PLSM.US](https://longbridge.com/en/quote/PLSM.US.md)
- [KTTAW.US](https://longbridge.com/en/quote/KTTAW.US.md)

## Related News & Research

- [IM Cannabis Stock Falls after $1.31 Million Offering Follows Drone Deal](https://longbridge.com/en/news/299915374.md)
- [Alaunos Therapeutics Announces New Registered Direct Offering](https://longbridge.com/en/news/299813835.md)
- [Alaunos Therapeutics Enters Securities Purchase Agreement With Accredited Investors](https://longbridge.com/en/news/299810727.md)
- [Telomir says Telomir-Zn restores visual function, retinal structure in AMD preclinical model](https://longbridge.com/en/news/299320678.md)
- [Telomir-Zn Preclinical Data Highlight Retinal Regeneration Potential](https://longbridge.com/en/news/299326201.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**